Megan Fant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Megan Fant has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andrew J. Krentz
School of Life Course & Population Sciences, King’s College London, Strand, London WC2R 2LS, UK
1 shared publication - Jennifer E. McCallum
St Gilesmedical London & Berlin, Suite 616, The Shepherds Building, Charecroft Way, West Kensington, London W14 0EE, UK
1 shared publication - Jing Han Ong
St Gilesmedical London & Berlin, Suite 616, The Shepherds Building, Charecroft Way, West Kensington, London W14 0EE, UK
1 shared publication - Lylah Drummond-Clarke
St Gilesmedical London & Berlin, Suite 616, The Shepherds Building, Charecroft Way, West Kensington, London W14 0EE, UK
1 shared publication - Oleksii Kozhevnikov
MedibiotiX GmbH, Dr.-Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany
1 shared publication - Sital Harris
Life Science Academy, Eastbourne, East Sussex BN21 3FG, UK
1 shared publication
Latest Publications
- Open Access
Nutraceuticals and Metabolic Health: Can Supplements Prevent Metabolic Syndrome? A Narrative Review
Metabolic syndrome (MetS) encompasses a spectrum of disease pathologies that include dyslipidaemia, insulin resistance, hypertension, obesity, and inflammation. The rising prevalence of MetS and the associated morbidity and mortality represent a growing burden on global healthcare. MetS’s hallmarks are readily quantified and can be used to assess development and progression of the syndrome. Nutraceuticals, bioactive compounds derived from natural sources such as plants, fruits, cultures and grains, have a potential role in protection against cardiometabolic diseases. Relevant actions of nutraceuticals include their antioxidant, probiotic, anti-inflammatory, insulin-sensitising, lipid-modifying, anti-adiposity, and endothelial protective functions. This review explores the evidence for common nutrient deficiencies in metabolic syndrome alongside their role in preventing and modifying the complex elements that characterise this prevalent disease cluster.
Open AccessNutraceuticals and Metabolic Health: Can Supplements Prevent Metabolic Syndrome? A Narrative Review
Metabolic syndrome (MetS) encompasses a spectrum of disease pathologies that include dyslipidaemia, insulin resistance, hypertension, obesity, and inflammation. The rising prevalence of MetS and the associated morbidity and mortality represent a growing burden on global healthcare. MetS’s hallmarks are readily quantified and can be used to assess development and progression of the syndrome. Nutraceuticals, bioactive compounds derived from natural sources such as plants, fruits, cultures and grains, have a potential role in protection against cardiometabolic diseases. Relevant actions of nutraceuticals include their antioxidant, probiotic, anti-inflammatory, insulin-sensitising, lipid-modifying, anti-adiposity, and endothelial protective functions. This review explores the evidence for common nutrient deficiencies in metabolic syndrome alongside their role in preventing and modifying the complex elements that characterise this prevalent disease cluster.